Robert Appleton
Modesto, CANPI 1861464273
Payments from drug & device makers
$1,380in general payments, 2019–2025
Across 66 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$416
- Regeneron Healthcare Solutions, Inc.$153
- Novo Nordisk$84
- Baxter Healthcare$69
- Neurelis, Inc.$66
- Supernus Pharmaceuticals, Inc.$62
- plus $530 from 20 others
What the payments were for
- Food & beverage$1,380100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 20 | $416 |
| Regeneron Healthcare Solutions, Inc. | 8 | $153 |
| Novo Nordisk | 4 | $84 |
| Baxter Healthcare | 3 | $69 |
| Neurelis, Inc. | 3 | $66 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Nestle Healthcare Nutrition Inc. | 3 | $54 |
| Sobi, Inc | 1 | $52 |
| PTC Therapeutics, Inc. | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Kyowa Kirin, Inc. | 2 | $41 |
| QOL Medical, LLC | 1 | $26 |
| Livanova USA, Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| AstraZeneca | 1 | $21 |
| Mirum Pharmaceuticals, Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Tolmar, Inc. | 1 | $18 |
| Zogenix Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| SK Life Science, Inc. | 1 | $15 |
| Albireo Pharma, Inc. | 1 | $15 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.